全文获取类型
收费全文 | 254311篇 |
免费 | 22421篇 |
国内免费 | 8460篇 |
专业分类
耳鼻咽喉 | 2179篇 |
儿科学 | 5961篇 |
妇产科学 | 2964篇 |
基础医学 | 40876篇 |
口腔科学 | 7571篇 |
临床医学 | 17062篇 |
内科学 | 35577篇 |
皮肤病学 | 3819篇 |
神经病学 | 17194篇 |
特种医学 | 7085篇 |
外国民族医学 | 59篇 |
外科学 | 36498篇 |
综合类 | 33296篇 |
现状与发展 | 31篇 |
一般理论 | 4篇 |
预防医学 | 11155篇 |
眼科学 | 2872篇 |
药学 | 30332篇 |
104篇 | |
中国医学 | 9129篇 |
肿瘤学 | 21424篇 |
出版年
2024年 | 446篇 |
2023年 | 3949篇 |
2022年 | 5584篇 |
2021年 | 10586篇 |
2020年 | 9930篇 |
2019年 | 10112篇 |
2018年 | 9456篇 |
2017年 | 9260篇 |
2016年 | 9483篇 |
2015年 | 10893篇 |
2014年 | 16230篇 |
2013年 | 17760篇 |
2012年 | 15943篇 |
2011年 | 18604篇 |
2010年 | 15667篇 |
2009年 | 14875篇 |
2008年 | 14022篇 |
2007年 | 12765篇 |
2006年 | 11466篇 |
2005年 | 9955篇 |
2004年 | 8741篇 |
2003年 | 7224篇 |
2002年 | 5667篇 |
2001年 | 4831篇 |
2000年 | 3947篇 |
1999年 | 3542篇 |
1998年 | 3004篇 |
1997年 | 2687篇 |
1996年 | 2299篇 |
1995年 | 1952篇 |
1994年 | 1657篇 |
1993年 | 1392篇 |
1992年 | 1112篇 |
1991年 | 1012篇 |
1990年 | 826篇 |
1989年 | 708篇 |
1988年 | 612篇 |
1987年 | 520篇 |
1986年 | 502篇 |
1985年 | 907篇 |
1984年 | 911篇 |
1983年 | 640篇 |
1982年 | 735篇 |
1981年 | 583篇 |
1980年 | 475篇 |
1979年 | 434篇 |
1978年 | 331篇 |
1977年 | 263篇 |
1976年 | 244篇 |
1975年 | 175篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
81.
82.
Mónica Berger-González Ana Vides-Porras Sarah Strauss Michael Heinrich Simeón Taquirá Pius Krütli 《Medical anthropology》2016,35(4):353-367
Biomedicine fosters particular styles of interaction and behaviors, with the therapeutic relationship seen as occurring between a doctor and patient. In contrast, where alternative modalities of healing are practiced, relationships go beyond a dyadic interaction and include wider social networks. In this article, we propose the existence of a ‘therapeutic unit’ in Maya healing practices in Guatemala that binds healer, wellness seeker, family, and community members, along with the spiritual and natural realms, into a coherent system requiring all of these elements to achieve success. Drawing on interviews with 67 Maya healers, we describe healers’ understanding of raxnaq’il nuk’aslemal (well-being), and show how these interactions activate wider networks that play crucial roles during treatments. We highlight how holism is expressed in relationships typical of indigenous healing systems, and how an appreciation of this is important for developing culturally appropriate health care provision systems. 相似文献
83.
动脉导管未闭(PDA)是早产儿常见疾病,目前早产儿PDA的自然发展过程仍未完全明确,PDA发生的有些高危因素仍存在争议,对PDA是否进行药物、手术干预,以及何时进行药物、手术干预仍存在争议。尽管已经有相当多的证据证实动脉导管持续开放可能有害,但目前尚缺乏关闭导管治疗方案的远期益处或害处的相关证据。大多数临床试验旨在评估短期导管开放对患儿的影响。目前尚无评估动脉导管持续开放对早产儿死亡率及并发症影响的临床试验。近年来PDA治疗上最大的变化是减少对PDA的治疗。该文重点总结胎龄28周早产儿PDA的治疗策略。 相似文献
84.
背景与目的以免疫检查点抑制剂(immune checkpoint inhibitors, ICIs)为代表的免疫治疗越来越广泛地应用于肺癌治疗。然而,对于程序性死亡受体配体1(programmed cell death-ligand 1, PD-L1)高表达,即肿瘤比例评分(tumor proportion score, TPS)≥50%的晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)患者,采用单纯免疫治疗还是免疫联合化疗在临床上仍存争议。本研究旨在评估PD-L1高表达的晚期NSCLC患者接受单纯免疫治疗与免疫联合化疗的疗效。方法本研究回顾性分析了49例PD-L1高表达晚期NSCLC患者的临床资料。PD-L1表达采用22C3抗体行免疫组化染色,按TPS判读PD-L1表达水平。比较不同临床特征分组患者的客观缓解率(objective response rate,ORR)和无进展生存时间(progression free survival, PFS)。结果免疫单药与免疫联合化疗组的ORR分别为47.1%(8/17)和43.8%(14/32),差异无统计学意义(P=0.825)。免疫单药与免疫联合化疗组的中位PFS分别为8.0个月和6.8个月,差异无统计学意义(P=0.502)。并对本组PD-L1高表达患者免疫治疗的预测因素进行了分析,结果显示,一线免疫治疗ORR(12/19, 63.2%)显著优于二线及以上免疫治疗(10/30, 33.3%),差异有统计学意义(P=0.041),二者间PFS无差异。年龄、性别、吸烟史、功能状态评分(performance status, PS)、病理类型、肿瘤大小、肿瘤淋巴结转移(tumor node metastasis, TNM)分期与ORR和PFS不相关。结论PD-L1高表达的晚期NSCLC患者接受免疫单药和免疫联合化疗的疗效相近。PD-L1高表达患者一线免疫治疗的ORR更佳。对此类人群的最佳治疗方案有待于前瞻性临床研究进一步探索。 相似文献
85.
《Clinical neurophysiology》2021,132(12):3104-3115
ObjectiveWe aimed to establish an objective neurophysiological test protocol that can be used to assess the somatosensory nervous system.MethodsIn order to assess most fiber subtypes of the somatosensory nervous system, repetitive stimuli of seven different modalities (touch, vibration, pinprick, cold, contact heat, laser, and warmth) were synchronized with the electroencephalogram (EEG) and applied on the cheek and dorsum of the hand and dorsum of the foot in 21 healthy subjects and three polyneuropathy (PNP) patients. Latencies and amplitudes of the modalities were assessed and compared. Patients received quantitative sensory testing (QST) as reference.ResultsWe found reproducible evoked potentials recordings for touch, vibration, pinprick, contact-heat, and laser stimuli. The recording of warm-evoked potentials was challenging in young healthy subjects and not applicable in patients. Latencies were shortest within Aβ-fiber-mediated signals and longest within C-fibers. The test protocol detected function loss within the Aβ-fiber and Aδ-fiber-range in PNP patients. This function loss corresponded with QST findings.ConclusionIn this pilot study, we developed a neurophysiological test protocol that can specifically assess most of the somatosensory modalities. Despite technical challenges, initial patient data appear promising regarding a possible future clinical application.SignificanceEstablished and custom-made stimulators were combined to assess different fiber subtypes of the somatosensory nervous system using modality-specific evoked potentials. 相似文献
86.
Rohi Shah Nomaan Sheikh Jitendra Mangwani Nicolette Morgan Hamidreza Khairandish 《Journal of Clinical Orthopaedics and Trauma》2021,12(1):138
Demographic projections for hip fragility fractures indicate a rising annual incidence by virtue of a multimorbid, ageing population with more noncommunicable diseases (NCDs). NCDs are characterised by slow progression and long duration ranging from ischaemic cardiovascular disease, cerebrovascular disease, diabetes, chronic obstructive pulmonary disease to various cancers. Management of this disease burden often involves commencing patients on oral anticoagulants to reduce the risk of thromboembolic events. The use of direct oral anticoagulants (DOACs) in clinical practice has increased due to their rapid onset of action, short half-life and predictable anticoagulant effects, without the need for routine monitoring. Safe and timely surgical intervention relies on reversal of anticoagulants. However, the lack of specific evidence-based guidelines for the perioperative management of patients on DOACs with hip fractures has proved challenging; in particular, the accessibility of DOAC-specific assays, justification of the cost-benefit ratio of targeted reversal agents and indications for neuraxial anaesthesia. This has led to potentially avoidable delays in surgical intervention. Following a literature review of the pharmacokinetic and pharmacodynamics of commonly used DOACs in our region including the role of surrogate markers, we propose a systematic, evidence-based guideline to the perioperative management of hip fractures DOACs. We believe this standardised protocol can be easily replicated between hospitals. We recommend that if patients are deemed suitable for a general anaesthesia, with satisfactory renal function, optimal surgical time should be 24 h following the last ingested dose of DOAC. 相似文献
87.
88.
89.
90.
目的:克隆人肠道病毒71型(EV71)及柯萨奇病毒A组16型(CA16)的VP1蛋白编码基因,构建相应真核表达质粒在体外进行重组表达,检测其细胞内定位,为EV71及CA16的疫苗研究提供基础。方法:通过PCR扩增分别获取EV71及CA16的VP1编码序列,插入pcFlag载体,分别构建EV71及CA16 VP1与FLAG标签融合的真核表达质粒;瞬时转染人胚肾293T细胞及横纹肌肉瘤RD细胞,Western blot法检测融合蛋白的表达,免疫荧光检测融合蛋白的细胞内定位情况。结果:测序表明两种来源VP1蛋白的重组表达质粒构建正确;分别转染两种不同的细胞后,均可通过Western blot检测到相应蛋白表达;免疫荧光检测显示两种毒株的VP1均表达在细胞质中。结论:外源融合表达EV71或CA16 VP1蛋白的真核表达质粒构建成功;所构建质粒分别转染细胞后,均可在细胞质内检测到VP1融合蛋白的表达。 相似文献